These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1719655)

  • 1. Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin (Enoxaparin) versus Dextran 70 in hip arthroplasty.
    Borris LC; Sørensen JV; Lassen MR; Walenga JM; Fareed J; Jørgensen LN; Hauch O; Wille-Jørgensen P
    Thromb Res; 1991 Jul; 63(1):21-8. PubMed ID: 1719655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. The Danish Enoxaparin Study Group.
    Arch Intern Med; 1991 Aug; 151(8):1621-4. PubMed ID: 1714709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-operative plasma levels of thrombin-antithrombin III complexes correlate with the development of venous thrombosis after major hip or knee surgery.
    Ginsberg JS; Brill-Edwards P; Panju A; Patel A; McGinnis J; Smith F; Dale I; Johnston M; Ofosu F
    Thromb Haemost; 1995 Aug; 74(2):602-5. PubMed ID: 8584991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactically equivalent doses of Enoxaparin and unfractionated heparin inhibit in vivo coagulation to the same extent.
    Ofosu FA; Levine M; Craven S; Dewar L; Shafai S; Blajchman MA
    Br J Haematol; 1992 Oct; 82(2):400-5. PubMed ID: 1329920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of thrombin--antithrombin-III complex and factor VIII activity in relation to post-operative deep vein thrombosis and influence of prophylaxis with a low-molecular-weight heparin.
    Sørensen JV; Borris LC; Lassen MR; Christiansen HM; Schøtt P; Olsen AD
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):389-92. PubMed ID: 1966794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery.
    Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
    Thromb Haemost; 1997 Feb; 77(2):267-9. PubMed ID: 9157579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between plasma levels of tissue plasminogen activator and postoperative deep vein thrombosis--influence of prophylaxis with a low molecular weight heparin. The Venous Thrombosis Group.
    Sørensen JV; Borris LC; Lassen MR; Christiansen HM; Schøtt P; Olsen AD; Neerstrand HS
    Thromb Res; 1990 Jul; 59(1):131-8. PubMed ID: 2169077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of a low molecular weight heparin (Logiparin) versus dextran as prophylaxis against thrombosis after total hip replacement.
    Mätzsch T; Bergqvist D; Fredin H; Hedner U
    Acta Chir Scand Suppl; 1988; 543():80-4. PubMed ID: 2461017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40.
    Francis CW; Pellegrini VD; Marder VJ; Harris CM; Totterman S; Gabriel KR; Baughman DJ; Roemer S; Burke J; Goodman TL
    J Bone Joint Surg Am; 1989 Mar; 71(3):327-35. PubMed ID: 2466846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of deep-vein thrombosis following total hip replacement surgery with enoxaparin versus unfractionated heparin: a pharmacoeconomic evaluation.
    Menzin J; Richner R; Huse D; Colditz GA; Oster G
    Ann Pharmacother; 1994 Feb; 28(2):271-5. PubMed ID: 8173149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
    Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
    Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
    Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
    Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombosis prophylaxis with low molecular weight heparin in total hip replacement.
    Eriksson BI; Zachrisson BE; Teger-Nilsson AC; Risberg B
    Br J Surg; 1988 Nov; 75(11):1053-7. PubMed ID: 2463035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoeconomic model of enoxaparin versus heparin for prevention of deep vein thrombosis after total hip replacement.
    Hawkins DW; Langley PC; Krueger KP
    Am J Health Syst Pharm; 1997 May; 54(10):1185-90. PubMed ID: 9161627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin compared with dextran as prophylaxis against thrombosis after total hip replacement.
    Mätzsch T; Bergqvist D; Fredin H; Hedner U
    Acta Chir Scand; 1990; 156(6-7):445-50. PubMed ID: 1695053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of plasma levels of prothrombin fragments 1 and 2 during thromboprophylaxis with a low-molecular-weight heparin.
    Sørensen JV; Lassen MR; Borris LC; Rahr HB; Jensen HP; Hoppensteadt D; Walenga JA; Fareed J
    Blood Coagul Fibrinolysis; 1992 Feb; 3(1):55-9. PubMed ID: 1320416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enoxaparin prophylaxis in elective hip surgery.
    Turpie AG
    Acta Chir Scand Suppl; 1990; 556():103-7. PubMed ID: 1963014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery.
    Dahl OE; Aspelin T; Arnesen H; Seljeflot I; Kierulf P; Ruyter R; Lyberg T
    Thromb Res; 1995 Nov; 80(4):299-306. PubMed ID: 8585042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical diagnosis of deep venous thrombosis after hip replacement surgery].
    Andreassen G; Dahl OE
    Tidsskr Nor Laegeforen; 1997 May; 117(14):2026-7. PubMed ID: 9235679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.